The Efficacy and Safety of Seladelpar for Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis

ABSTRACT Background and Objective Seladelpar is an oral, once‐daily medication that improves cholestasis through its selective peroxisome proliferator‐activated receptor (PPAR‐δ) agonism. It shows promising efficacy in treating primary biliary cholangitis (PBC) patients. Methods A systematic review...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mohamed Abuelazm, Saqr Alsakarneh, Mohammad Tanashat, AlMothana Manasrah, Ahmed A. Ibrahim, Sandesh Parajuli, Hatem Eltaly, Ahmed Mazen Amin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-09-01
coleção:	JGH Open
Assuntos:	biliary drug gallbladder hepatology liver seladelpar
Acesso em linha:	https://doi.org/10.1002/jgh3.70265
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!